Transplant News and Research

RSS

Study: Biologic response modifying drugs can cause acute liver injury

A commonly used class of biologic response modifying drugs can cause acute liver injury with elevated liver enzymes, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

30 Apr 2013

Researchers say tiny thymus teaches immune system to ignore foreign bacteria in gut

The tiny thymus teaches the immune system to ignore the teeming, foreign bacteria in the gut that helps you digest and absorb food, researchers say.

30 Apr 2013

Veloxis seeks EMA approval to market LCP-Tacro for kidney transplant patients

Veloxis Pharmaceuticals A/S today announced that it has submitted a Marketing Authorization Application to the European Medicines Agency seeking approval to market LCP-Tacro for the prevention of organ rejection in kidney transplant patients in the European Union.

29 Apr 2013

Opsona raises €33M in oversubscribed financing round

Opsona Therapeutics Limited, the innate immune drug development company, today announced that it has raised €33 million (US $ 43 million) in an oversubscribed Series C financing.

29 Apr 2013

Baby boomers need to get tested for hepatitis C

If you were born during 1945-1965, talk to your doctor about getting tested for hepatitis C. Baby boomers are five times more likely than other adults to be infected. In fact, 75 percent of adults with hepatitis C were born during these years.

29 Apr 2013

New clinical algorithm to treat complex pediatric patients with ARPKD

A collaborative team of physician-scientists at the Medical College of Wisconsin and Children's Hospital of Wisconsin Research Institute has developed a new evidence-based, clinical algorithm to help physicians treat complex patients with autosomal recessive polycystic kidney disease.

29 Apr 2013

BIOMARGIN research project aims to prevent, diagnose lesions in transplanted kidneys

The BIOMARGIN (BIOMArkers of Renal Graft INjuries in kidney allograft recipients) research project, coordinated by INSERM, has just received financing from the "health" seventh framework programme of the European Commission to the tune of 6 million euros for a four-year period.

29 Apr 2013

Study reports liver donors face mortality risk with LDLT

A study published in Liver Transplantation, a journal of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, reports that donor mortality is about 1 in 500 donors with living donor liver transplantation (LDLT).

26 Apr 2013

Bucksbaum Institute of Clinical Excellence conducts second annual symposium on April 26

Jerome Lowenstein, MD, founder and director of the Program for Humanistic Aspects of Medical Education at New York University, will be the keynote speaker at the Bucksbaum Institute of Clinical Excellence's second annual symposium on Friday, April 26.

26 Apr 2013

Calcipotriol drug offers a potential treatment option for fibrotic diseases

Liver fibrosis results from an excessive accumulation of tough, fibrous scar tissue and occurs in most types of chronic liver diseases. In industrialized countries, the main causes of liver injury leading to fibrosis include chronic hepatitis virus infection, excess alcohol consumption and, increasingly, nonalcoholic steatohepatitis (NASH).

26 Apr 2013

Stem cell transplant regimen to treat neuroblastoma in children appears to be more toxic in US

The stem cell transplant regimen that was commonly used in the United States to treat advanced neuroblastoma in children appears to be more toxic than the equally effective regimen employed in Europe and Egypt, according to a new study to be presented at the 26th annual meeting of the American Society of Pediatric Hematology Oncology in Miami April 24-27.

25 Apr 2013

Living liver donors at risk from life-threatening “near-miss” events?

25 Apr 2013

Transplant, MCS physicians examine value of hTEE management at symposium in Montreal

ImaCor Inc., the developer of the world's only hemodynamic transesophageal echocardiography management device, announced today that transplant and mechanical circulatory support physicians from around the world gathered in Montreal at an hTEE symposium to hear from heart failure experts about the value of hTEE management.

25 Apr 2013

Experts say there is more need for organ donation in Hispanic community

April is National Donate Life Month, held to encourage organ and tissue donation and to celebrate donors who give a new life to others. Organ donors are always in short supply. In the United States, more than 118,000 people are waiting for organ transplants, and 19 percent are Hispanic.

25 Apr 2013

U.S. files suit against Novartis in alleged kickback scheme

The suit accuses the drugmaker of giving pharmacies discounts and rebates to promote the use of the drug Myfortic.

25 Apr 2013

Higher TMAO blood levels linked to increased risk of heart disease

A microbial byproduct of intestinal bacteria contributes to heart disease and serves as an accurate screening tool for predicting future risks of heart attack, stroke and death in persons not otherwise identified by traditional risk factors and blood tests, according to Cleveland Clinic research published today in The New England Journal of Medicine.

25 Apr 2013

Targeted screening for chronic hepatitis C virus infection is cost-effective, say researchers

Researchers at the University of Cincinnati have found that targeted screening for populations with a higher estimated prevalence for hepatitis C may be cost-effective.

25 Apr 2013

First Edition: April 24, 2013

Today's headlines include stories about the health law's implementation as well as health policy developments from Capitol Hill.

24 Apr 2013

Nanogels to attack lupus: an interview with Dr Look and Dr Fahmy, Yale University

Nanogels are synthetic particles that can be used for drug delivery. They are approximately 100 nm to 200 nm in diameter, and are made from safe, biocompatible materials: a gel-like interior and a lipid exterior.

24 Apr 2013

Study: Nearly two-thirds of children receiving stem cell transplants return to hospital within six months

Nearly two-thirds of children receiving stem cell transplants returned to the hospital within six months for treatment of unexplained fevers, infections or other problems, according to a study performed at Dana-Farber/Children's Hospital Cancer Center in Boston.

24 Apr 2013

Transplant News and Research

Study: Biologic response modifying drugs can cause acute liver injury

Researchers say tiny thymus teaches immune system to ignore foreign bacteria in gut

Veloxis seeks EMA approval to market LCP-Tacro for kidney transplant patients

Opsona raises €33M in oversubscribed financing round

Baby boomers need to get tested for hepatitis C

New clinical algorithm to treat complex pediatric patients with ARPKD

BIOMARGIN research project aims to prevent, diagnose lesions in transplanted kidneys

Study reports liver donors face mortality risk with LDLT

Bucksbaum Institute of Clinical Excellence conducts second annual symposium on April 26

Calcipotriol drug offers a potential treatment option for fibrotic diseases

Stem cell transplant regimen to treat neuroblastoma in children appears to be more toxic in US

Living liver donors at risk from life-threatening “near-miss” events?

Transplant, MCS physicians examine value of hTEE management at symposium in Montreal

Experts say there is more need for organ donation in Hispanic community

U.S. files suit against Novartis in alleged kickback scheme

Higher TMAO blood levels linked to increased risk of heart disease

Targeted screening for chronic hepatitis C virus infection is cost-effective, say researchers

First Edition: April 24, 2013

Nanogels to attack lupus: an interview with Dr Look and Dr Fahmy, Yale University

Study: Nearly two-thirds of children receiving stem cell transplants return to hospital within six months

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News